Over the past six months, Solventum’s stock price fell to $67.18. Shareholders have lost 6% of their capital, which is disappointing considering the S&P 500 has climbed by 2.6%. This may have ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Solventum has acquired US-based Acera Surgical in a deal worth up to $850m, positioning the company to progress in the synthetic tissue matrices technology space. Solventum, which span out from 3M in ...

Solventum, the recently spun off healthcare arm of 3M, faces challenges in value creation due to stagnant growth, heavy debt burden, and entanglement with its former parent. The company's revenue ...

Pzena Investment Management recently released its third-quarter 2025 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. Driven by optimism about AI and a ...

On Thursday, Solventum (NYSE:SOLV) hosted its 2025 Investor Day, during which it outlined its strategic priorities, its business segments, and its long-range plan (LRP) to drive growth and value ...

President and Chief Executive Officer — Bryan C. Hanson Chief Financial Officer — Wayde D. McMillan Head of Investor Relations — Amy Wakeham Management stated the company is actively evaluating ...

It's always interesting when a new company comes to market and doubly interesting when it's a spinoff. In reality, two new companies came out of the spinoff of Solventum (NYSE: SOLV) and 3M (NYSE: MMM ...

ST. PAUL, Minn., April 1, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that its spin-off from 3M (NYSE: MMM) is complete and the newly independent healthcare company will begin trading ...

Solventum Corporation SOLV is well-poised for growth in the coming quarters, driven by strong demand across its business segments, supported by continued investment in innovation, R&D and digital ...